Appili Therapeutics (Appili Therapeutics) Change In Payables And Accrued Expense : $0.52 Mil (TTM As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Appili Therapeutics Change In Payables And Accrued Expense?

Appili Therapeutics's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2023 was $0.10 Mil. It means Appili Therapeutics's Accounts Payable & Accrued Expense increased by $0.10 Mil from Sep. 2023 to Dec. 2023 .

Appili Therapeutics's Change In Payables And Accrued Expense for the fiscal year that ended in Mar. 2023 was $-3.04 Mil. It means Appili Therapeutics's Accounts Payable & Accrued Expense declined by $3.04 Mil from Mar. 2022 to Mar. 2023 .

Appili Therapeutics Change In Payables And Accrued Expense Historical Data

The historical data trend for Appili Therapeutics's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Appili Therapeutics Change In Payables And Accrued Expense Chart

Appili Therapeutics Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

0.07

0.01

2.55

1.52

-3.04

Appili Therapeutics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															0.79	-0.15	0.07	0.50	0.10

Appili Therapeutics Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.52 Mil.

Appili Therapeutics Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Appili Therapeutics's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Appili Therapeutics (Appili Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Appili Therapeutics Inc (OTCPK:APLIF) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

APLI:Canada

Address

1344 Summer Street, Suite 21, Halifax, NS, CAN, B3H 0A8

Website

https://www.appilitherapeutics.com

Appili Therapeutics Inc is a biopharmaceutical company. The company is engaged in novel antibiotic and anti-infective therapies to help patients suffering from serious infections. Its anti-infective portfolio currently includes major programs namely ATI-2307, ATI-1701, ATI-1503, ATI-1501 and Favipiravir.